Intracavernous injections of prostaglandin E1 for erectile dysfunction:multicenter study

Intracavernous injections of prostaglandin E1 for erectile dysfunction:multicenter study - Intracavernous injections of prostaglandin E1 for erectile dysfunction:multicenter study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012394

Enrollment

200

Registered

2013-12-10

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Interventions

prostaglandin E1

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Obtaining of written informed consent 2) contraindication or unavailable of Phosophodiesterase5 inhibitor 3) Patienthad a good responce of PGE1-ICI

Exclusion criteria

Exclusion criteria: 1) cases with diseases of dementia or mental disease 2) cases with past history of allergic reaction to medicine 3)Patients was deemed by the physician as inappropriate to attend. 4) priapism(past history, drepanocyte, eukemia,multiple myeloma )

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of intracavernous injections of prostaglandin E1	—

Countries

Japan

Contacts

Public ContactAtsushi Nagai

Kawasaki medical school Department of Urology

nagai@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026